Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.

Key PointsHis purchases increased his exposure to pharmaceuticals, medical devices, diagnostics, and diabetes care.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

More from Monday 24 August →